VR Logo

Dyadic International Inc. (DYAI) download report


Healthcare | Biotechnology & Pharma Research

Dyadic International Inc. (DYAI) Premium Coverage

53 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Dyadic International, Inc., a biotechnology platform company, develops, produces, and sells enzymes and other proteins in the United States.

IPO Date: 05-Nov-2004

Founder, CEO, Pres & Director: Mr. Mark A. Emalfarb

Chief Financial Officer: Ms. Ping Wang Rawson CPA, M.B.A.

Listing: NASDAQ: DYAI

Country: United States

Headquarters: Jupiter, FL

Website: https://www.dyadic.com

Key Facts

Market cap: $85.92 Mln

Revenue (TTM): $2.59 Mln

Earnings (TTM): $-12.27 Mln

Cash: $15.44 Mln

Total Debt: $0.00 Mln

Insider's Holding: 29.56%

Liquidity: Low

52 Week range: $1.74 - 6.89

Shares outstanding: 28,264,200

10 Years Aggregate:

  • CFO: $-38.22 Mln
  • EBITDA: $-53.94 Mln
  • Net Profit: $18.59 Mln

Stock Performance

Time Period Dyadic International (DYAI) S&P BSE Sensex* S&P Small-Cap 600*
YTD-32.74-8.62-18.78
1 month31.03-4.54-8.00
3 months1.00-10.19-13.65
1 Year-15.321.43-17.19
3 Years-21.4010.146.10
5 Years17.2811.265.87
10 Years11.1111.829.84
As on 01-Jul-2022 *As on 04-Jul-2022
Year Dyadic International (DYAI) S&P Small-Cap 600 S&P BSE Sensex
2021-15.9925.2721.99
20203.869.5715.75
2019174.0720.8614.38
201835.74-9.705.87
2017-16.2711.7327.91
2016-8.2924.741.95
201592.55-3.36-5.03